R-CHOP: — What Each Drug in the Regimen Does
R-CHOP is the most widely used combination regimen for aggressive B-cell lymphoma. It pairs a targeted antibody — rituximab — with four chemotherapy drugs, each attacking cancer cells through a different mechanism. Understanding what each component does can help you make sense of your treatment plan and what to expect.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Five drugs, four mechanisms — Each component works differently, reducing the chance that lymphoma cells can become resistant to any single drug.
- Rituximab is the targeted part — It marks B-cells for destruction by your immune system. The chemotherapy drugs work more broadly, affecting dividing cells.
- Given as day care — Each cycle is given at the clinic. You go home the same day in most centres.
- Other rituximab combinations exist — R-CVP and R-Bendamustine are used for different lymphoma types. Your oncologist chooses based on your exact diagnosis.
on Panel
Survival Rate*
Treated
(800+ reviews)
R-CHOP pairs rituximab — a targeted antibody — with four chemotherapy drugs: cyclophosphamide, doxorubicin, vincristine, and prednisolone. Each component attacks B-cell lymphoma in a different way, reducing the chance that cancer cells can become resistant to any single drug. NCCN and ESMO recommend this combination as the standard first-line treatment for diffuse large B-cell lymphoma.
What does each letter of R-CHOP stand for?
- R — Rituximab (MabThera)
- A monoclonal antibody that targets a protein called CD20 on the surface of B-cells. It attaches to lymphoma cells and flags them for destruction by your immune system. Most healthy non-B cells do not carry CD20, so rituximab is more selective than the chemotherapy drugs in the regimen.
- C — Cyclophosphamide
- An alkylating agent that damages the DNA inside cancer cells, stopping them from copying themselves. It is active across the full cell cycle, which is part of why combination regimens include it alongside drugs that target specific points in cell division.
- H — Hydroxydaunorubicin (Doxorubicin)
- An anthracycline that disrupts how cancer cells copy and organise their DNA, triggering cell death. It is given through a drip. Because it can affect heart function at high cumulative doses, your team will check your heart before starting and monitor it during treatment.
- O — Oncovin (Vincristine)
- A plant-derived drug that prevents cancer cells from completing division by blocking the cellular machinery needed to pull chromosomes apart. It is given in small doses. The most common side effect is numbness or tingling in the fingers and toes, which often improves after treatment ends.
- P — Prednisolone
- A corticosteroid with direct anti-lymphoma activity, not only a drug to manage side effects. It also reduces the inflammation that can occur when large numbers of cancer cells die rapidly. Unlike the other components, it is taken as tablets — usually for several days around each infusion — rather than given through a drip.
Why use five drugs together instead of one?
Each drug in R-CHOP attacks a different step in how a cancer cell survives and divides. Using several together means that even if a lymphoma cell develops resistance to one mechanism, the others are still active against it.
Rituximab adds something the chemotherapy drugs cannot provide. It recruits your own immune system to destroy marked lymphoma cells. The three chemotherapy drugs — cyclophosphamide, doxorubicin, and vincristine — each target a different point in the cell division process.
Prednisolone's role is also more than supportive. It has direct cell-killing activity in B-cell lymphoma and reduces the inflammatory response that can follow rapid tumour breakdown.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What does a course of R-CHOP treatment look like?
R-CHOP is given in cycles, each separated by a rest period that gives your body time to recover. The number of cycles your oncologist recommends depends on your lymphoma type, stage, and response to treatment. Each cycle is given at the clinic and you go home the same day.
Rituximab is infused first and given slowly on the first cycle, because initial doses carry a higher chance of a reaction. Later cycles can often be given faster once your team is confident you tolerate it. The chemotherapy drugs follow. You take prednisolone tablets at home for several days around each infusion.
Your blood count is checked closely between cycles. A low white cell count is the most common reason for a cycle to be delayed. If you develop any fever or feel generally unwell between appointments, call your team the same day — do not wait for your next scheduled visit.
Are there other rituximab combinations besides R-CHOP?
Yes. Rituximab is used with different chemotherapy backbones depending on the lymphoma type and grade. R-CVP — rituximab with cyclophosphamide, vincristine, and prednisolone, without doxorubicin — is used for some lower-grade follicular lymphomas, particularly where avoiding cardiac risk is a priority.
R-Bendamustine pairs rituximab with bendamustine and is used for certain follicular and mantle cell lymphomas. Other combinations exist for specific lymphoma subtypes.
The choice is made by your oncologist based on your exact diagnosis, your age, your heart function, and your overall health. If you want to understand why a particular regimen was chosen for you, that is a reasonable question to ask at your next appointment.
Explore 75 more Blood Cancer Targeted Medicines topics
Drug Deep Dive: Rituximab (MabThera)
- Diet and Nutrition While on Rituximab
- Drug, Food and Supplement Interactions With Rituximab
- Fertility, Pregnancy and Contraception on Rituximab
- Hepatitis B Reactivation and Rituximab: The Test You Must Not Skip
- How Does Rituximab Work? The Anti-CD20 Monoclonal Antibody Explained
- How Long Does Rituximab Take to Work?
- How Long Will You Stay on Rituximab?
- Low Antibodies and Repeated Infections After Rituximab
- MabThera vs Biosimilar Rituximab in India: Cost and Equivalence
- R-CHOP and Other Rituximab Combinations Explained
- Rituximab (MabThera, Ristova and biosimilars): The Complete Patient Guide
- Rituximab Infusion Day: Premedication, Duration and What to Expect
- Rituximab Infusion Reactions: Why the First Infusion Is Different
- Rituximab Maintenance: Two More Years of Infusions, and Why
- Rituximab Myths: Vaccines, Immunity and 'Permanent Damage'
- Rituximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Rituximab Side Effects: The Complete List and Timeline
- Rituximab Success Rate and Survival: An Honest Look at the Numbers
- Rituximab in Elderly Patients and Those With Other Illnesses
- Tests and Monitoring While You Are on Rituximab
- When Rituximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Rituximab? B-Cell Lymphoma and CLL
- Why the Same Drug Treats Arthritis and Lymphoma
- Will Insurance or a Government Scheme Pay for Rituximab?
- Work, Travel and Daily Life on Rituximab
Drug Deep Dive: Ibrutinib (Imbruvica)
- Diarrhoea, Joint Pain and Infection Risk on Ibrutinib
- Diet and Nutrition While on Ibrutinib
- Easy Bruising and Bleeding on Ibrutinib: What Is Normal and What Is Not
- Fertility, Pregnancy and Contraception on Ibrutinib
- How Does Ibrutinib Work? The BTK Inhibitor Explained
- How Long Does Ibrutinib Take to Work?
- How Long Will You Stay on Ibrutinib?
- Ibrutinib (Imbruvica, Ibrutix): The Complete Patient Guide
- Ibrutinib Interactions: Blood Thinners, Antifungals and Fish Oil
- Ibrutinib Myths: Lifelong Treatment, Bruising and 'It's Not Real Treatment'
- Ibrutinib Price in India: Brand, Generic and Monthly Cost
- Ibrutinib Side Effects: The Complete List and Timeline
- Ibrutinib Success Rate and Survival: An Honest Look at the Numbers
- Ibrutinib With Rituximab or Venetoclax: Continuous vs Fixed-Duration Therapy
- Ibrutinib in CLL, Mantle Cell Lymphoma and Waldenstrom's
- Ibrutinib in Elderly Patients and Those With Other Illnesses
- Ibrutinib vs Acalabrutinib vs Zanubrutinib: Comparing BTK Inhibitors
- Palpitations, Atrial Fibrillation and High Blood Pressure on Ibrutinib
- Surgery and Dental Procedures on Ibrutinib: The Bleeding Rule
- Taking Ibrutinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Ibrutinib
- When Ibrutinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Ibrutinib? CLL, Mantle Cell Lymphoma and Waldenstrom's Macroglobulinaemia
- Will Insurance or a Government Scheme Pay for Ibrutinib?
- Work, Travel and Daily Life on Ibrutinib
Drug Deep Dive: Imatinib (Gleevec)
- Adjuvant Imatinib After GIST Surgery: How Many Years?
- BCR-ABL PCR Monitoring: What 'Log Reduction' and 'MR4.5' Mean
- Can You Ever Stop Imatinib? Treatment-Free Remission Explained
- Diet and Nutrition While on Imatinib
- Fertility, Pregnancy and Contraception on Imatinib
- How Does Imatinib Work? The BCR-ABL and KIT Inhibitor Explained
- How Long Does Imatinib Take to Work?
- Imatinib (Gleevec, Veenat, Imatib): The Complete Patient Guide
- Imatinib Interactions: Paracetamol, Antacids and Herbal Medicines
- Imatinib Myths: Lifelong Dependence, Fertility and Generic Quality
- Imatinib Price in India: Brand, Generic and Monthly Cost
- Imatinib Side Effects: The Complete List and Timeline
- Imatinib Success Rate and Survival: An Honest Look at the Numbers
- Imatinib for GIST: How It Differs From CML Treatment
- Imatinib in Elderly Patients and Those With Other Illnesses
- Imatinib vs Nilotinib vs Dasatinib: Choosing a CML Drug
- Muscle Cramps and Bone Pain on Imatinib: What Actually Helps
- Nausea, Stomach Upset and Weight Gain on Imatinib
- Puffy Eyes and Swollen Legs on Imatinib: Managing Fluid Retention
- Taking Imatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Imatinib
- When Imatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Imatinib? Chronic Myeloid Leukaemia and GIST
- Will Insurance or a Government Scheme Pay for Imatinib?
- Work, Travel and Daily Life on Imatinib
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Is R-CHOP the same as CHOP — what does rituximab actually add?
CHOP on its own was the standard regimen for aggressive B-cell lymphoma for many years. When rituximab was added to form R-CHOP, outcomes improved substantially for patients whose lymphoma cells carry the CD20 protein — which the majority do. Rituximab adds a targeted mechanism that the chemotherapy drugs cannot provide: it flags cancer cells specifically for destruction by your immune system. NCCN and ESMO now recommend R-CHOP, not CHOP alone, as the standard first-line treatment for eligible patients with diffuse large B-cell lymphoma.
Can R-CHOP damage my heart?
Doxorubicin — the H in CHOP — can affect heart function, particularly when the total dose received across all cycles is high. Before starting R-CHOP, your team will check your baseline heart function, usually with an echocardiogram, and monitor it during treatment. Most people complete a standard course without lasting cardiac effects. If you have existing heart disease, your oncologist will weigh the balance carefully and may recommend a different regimen, such as R-CVP, which does not contain doxorubicin.
What should I do if I develop a fever between cycles?
Call your oncology team the same day and do not wait for your next appointment. A fever when your white cell count is low — called febrile neutropenia — needs same-day assessment, not home management. Your team will tell you before your first cycle what number to call and when to go directly to an emergency department. Avoid taking fever-reducing medicines before speaking to your team, as these can mask a symptom your team needs to be aware of.
Will my hair fall out during R-CHOP?
Hair loss is expected with R-CHOP, primarily because of doxorubicin, and affects most people on this regimen. It usually begins in the weeks after the first cycle. Hair typically starts to grow back after treatment ends. Some people choose to cut their hair short before treatment begins, or to ask about scalp cooling — ask your team whether that option is available and suitable for your situation.
Are there foods or drinks I should avoid during R-CHOP?
Your team will give you specific guidance for your situation. General advice during chemotherapy includes avoiding grapefruit and grapefruit juice, which can interfere with how some drugs are processed in the body. When your white cell count is low, your team may advise extra care with raw or undercooked food to reduce infection risk. Do not take herbal remedies, supplements, or traditional preparations without telling your treating team first — some interact with chemotherapy drugs in ways that affect how they work or increase side effects.
Can I work or travel normally during R-CHOP?
Many people continue working and managing most normal activities during R-CHOP, particularly in the weeks between cycles when energy levels are closer to usual. The days immediately after an infusion are often the most difficult — fatigue, nausea, and reduced immunity are most pronounced then. Travel, particularly international travel, should be discussed with your team in advance, because access to emergency care if you develop a fever matters. Your team can advise on timing around your cycle schedule.